Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CON | FMS |
|---|---|---|
| Price | $36.21 | $22.65 |
| Change today | ▲ 1.57% | ▲ 1.80% |
| Market cap | $4.62B | $12.05B |
| Return, 3 months | +14.7% | -6.4% |
| Return, year to date | +85.3% | -1.1% |
| Return, 1 year | +77.2% | -11.9% |
| P/E (TTM) | 23.4 | 12.2 |
| P/B | 9.7 | 0.9 |
| P/E percentile vs own 5y | 99th | 15th |
| Dividend yield | 0.69% | 3.77% |
| Revenue growth (YoY, latest qtr) | +13.9% | +1.4% |
| Net profit growth (YoY) | +0.6% | +7.7% |
| Gross margin | 28.3% | 26.4% |
| Operating margin | 15.4% | 10.2% |
| Net margin | 8.0% | 4.8% |
| Return on equity | – | 7.3% |
| Analyst target vs. price | +13.2% | +4.1% |
| Analyst buy share | 90% | 0% |
| RSI (14) | 62 | 50 |
| 30-day volatility | 21.5% | 20.0% |
| Max drawdown, 1 year | -13.3% | -26.3% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
